Product Information
ALBENDAZOLE 200 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $4.1922 per EA under NDC 00591271202. Its NADAC has been published 372 times since Jul 10, 2019.
FDA first approved this application on May 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591271202
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALBENDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA208094FDA Approved
5/20/2019
TE Code
AB
On Market Since
6/13/2019
Pharmacological Classes
Price Statistics
The NADAC for ALBENDAZOLE 200 MG TABLET has been published 372 times since Jul 10, 2019, and over the history we have for it it has declined 97.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1922 per EA |
|---|---|
| All-time high | $139.8767 (Jul 10, 2019) |
| All-time low | $4.0304 (Apr 22, 2026) |
| 52-week high | $6.0235 |
| 52-week low | $4.0304 |
| Median price | $12.6089 |
| Average price | $28.3107 |
| Largest weekly change | +59.8% (Dec 22, 2021) |
| Weeks tracked | 372 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALBENDAZOLE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALBENDAZOLE 200 MG TABLET, manufactured by Actavis Pharma, Inc., is $4.1922 per EA (NDC 00591271202), effective Aug 19, 2026.
How has the price of ALBENDAZOLE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALBENDAZOLE 200 MG TABLET has declined 97.0%. It has been tracked across 372 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for ALBENDAZOLE 200 MG TABLET?
Since Jul 10, 2019, the NADAC for ALBENDAZOLE 200 MG TABLET has ranged from a low of $4.0304 (Apr 22, 2026) to a high of $139.8767 (Jul 10, 2019), with a median of $12.6089 per EA.
Are there cheaper alternatives to ALBENDAZOLE 200 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALBENDAZOLE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALBENDAZOLE 200 MG TABLET?
ALBENDAZOLE 200 MG TABLET (NDC 00591271202) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.